Owned prior to appointment. Wasn't part of a package etc or would have been declared.Lecram, could have been more astute and bought even more Probably thinking the same at this point. Problem for directors though is they can never really sell.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025